Analyst Consensus ?
ConsensusHold31 ratings
Bullish1548.4%
Neutral1548.4%
Bearish13.2%
1 unmapped firm rating excluded from the percentages.
Public Service Enterprise Group Incorporated · PEG · FY2025 Q1 · Calendar Q2 2025
PSEG reaffirms 2025 outlook as data-center pipeline expands
PSEG's Q1 update supports a steady, investment-led outlook: management reaffirmed full-year earnings guidance while highlighting strong nuclear performance and a larger large-load pipeline. Regulatory and affordability issues remain the key counterweights.
Reported Before market openNYSEUtilities
$34.99B market cap
80quality score
Earnings scorecard
Reported versus consensus
Reported EPS
—
Consensus $1.43
EPS surprise
—
Reported versus consensus
Reported revenue
—
Consensus $3.15B
Revenue surprise
—
Reported versus consensus
Market reaction
prior-close to event-session close
Stock move
-2.1%
Event window
SPY move
+0.0%
Same window
Abnormal move
-2.1%
Stock minus SPY
Volume
1.5×
Versus trailing sessions
Subsequent drift
-0.5%
Up to 20 sessions
PEGSPY benchmark
Ask FN2 about PEG FY2025 Q1
Transcript, numbers and history already loaded
What drove PEG's -2.1% move after FY2025 Q1 earnings?What changed in PEG's guidance and outlook in FY2025 Q1?Give me the bull and bear case for PEG after FY2025 Q1 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Management reaffirmed full-year non-GAAP earnings guidance and said the large-load pipeline exceeded 6,400 MW. The call also highlighted a 99.9% nuclear capacity factor and ongoing New Jersey regulatory discussions.
Guidance delta
Maintained: management reaffirmed full-year non-GAAP earnings guidance.
Key takeaways
- Q1 non-GAAP operating earnings were $1.43 per share, while full-year guidance was reaffirmed.
- The large-load pipeline exceeded 6,400 MW, creating potential future cost-recovery opportunities.
- Nuclear generation reached an 8.4 TWh output and a 99.9% capacity factor, while New Jersey affordability and regulatory issues remained in focus.
Management priorities
- Execute the $21-$24 billion five-year regulated capital plan through 2029.
- Roll out Phase 2 of the Clean Energy Future - Energy Efficiency II program.
- Pursue additional large-load interconnections and potential regulated generation sites.
- Continue nuclear operations and engage with New Jersey regulators on affordability measures and BGS mitigation.
Follow PEG with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$70.21Previous close
$70Low
$85.79Average
$98High
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Oct 16, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Truist Securities | Hold | Hold | Maintain | Oct 15, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Sep 18, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Aug 5, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Aug 5, 2026 |
| Jefferies | Hold | Hold | Maintain | Jul 20, 2026 |
| BMO Capital | Market Perform | Market Perform | Maintain | Apr 13, 2026 |
| Ladenburg Thalmann | Neutral | Buy | Downgrade | Mar 13, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Mar 12, 2026 |
| Evercore ISI Group | Outperform | In Line | Upgrade | Mar 5, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Mar 5, 2026 |
| UBS | Buy | Buy | Maintain | Dec 17, 2025 |
| TD Cowen | Buy | Buy | Maintain | Nov 5, 2025 |
| Guggenheim | Buy | Buy | Maintain | May 1, 2025 |
| B of A Securities | Buy | Buy | Maintain | Mar 3, 2025 |
| Scotiabank | Sector Perform | Sector Perform | Maintain | Dec 12, 2024 |
| RBC Capital | Outperform | Outperform | Maintain | Jul 15, 2024 |
| Mizuho | Buy | Buy | Maintain | May 23, 2024 |
| Seaport Global | Neutral | Buy | Downgrade | Jun 20, 2023 |
| Wolfe Research | Peer Perform | Outperform | Downgrade | Nov 17, 2022 |
| Goldman Sachs | Buy | Buy | Maintain | Oct 4, 2022 |
| Credit Suisse | Neutral | Neutral | Maintain | May 4, 2022 |
| Keybanc | Overweight | Downgrade | Jan 13, 2022 | |
| Vertical Research | Buy | Hold | Upgrade | Sep 30, 2021 |
| Deutsche Bank | Hold | Buy | Downgrade | Feb 28, 2019 |
| Argus Research | Buy | Buy | Maintain | Oct 17, 2018 |
| Argus | Buy | Buy | Maintain | Oct 17, 2018 |
| Macquarie | Outperform | Outperform | Maintain | Sep 24, 2018 |
| Bank of America | Buy | Neutral | Upgrade | Apr 16, 2018 |
| Tudor Pickering | Hold | Hold | Maintain | Dec 5, 2012 |
| ISI Group | Hold | Sell | Upgrade | Nov 9, 2012 |
| FBR Capital | Underperform | Market Perform | Downgrade | Aug 27, 2012 |
| Bank oferica | Neutral | Neutral | Maintain | Mar 12, 2012 |
Named analyst price targets
Upside is calculated against the persisted previous close $70.21. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Truist Financial | Analyst unavailable | $78 | $70.53 | +11.1% | Oct 15, 2026 |
| Argus Research | Analyst unavailable | $86 | $66.9 | +22.5% | Sep 29, 2026 |
| Morgan Stanley | Analyst unavailable | $88 | $70.16 | +25.3% | Sep 18, 2026 |
| Morgan Stanley | David Arcaro | $91 | $74.19 | +29.6% | Aug 21, 2026 |
| Truist Financial | Richard Sunderland | $84 | $75.98 | +19.6% | Aug 13, 2026 |
| Morgan Stanley | Analyst unavailable | $93 | $78.84 | +32.5% | Jul 22, 2026 |
| Jefferies | Paul Zimbardo | $78 | $78.64 | +11.1% | Jul 20, 2026 |
| RBC Capital | Stephen D'Ambrisi | $81 | $80.27 | +15.4% | Jul 1, 2026 |
| Truist Financial | Richard Sunderland | $88 | $76.44 | +25.3% | May 18, 2026 |
| Truist Financial | Analyst unavailable | $91 | $80.74 | +29.6% | Apr 20, 2026 |
| Jefferies | Analyst unavailable | $89 | $82.05 | +26.8% | Apr 14, 2026 |
| Scotiabank | Andrew Weisel | $92 | $85.85 | +31.0% | Feb 26, 2026 |
| Morgan Stanley | Analyst unavailable | $90 | $85.36 | +28.2% | Feb 20, 2026 |
| BTIG | Alex Kania | $94 | $82 | +33.9% | Jan 30, 2026 |
| Barclays | Analyst unavailable | $81 | $79.77 | +15.4% | Jan 22, 2026 |
| Morgan Stanley | Analyst unavailable | $92 | $79.28 | +31.0% | Jan 21, 2026 |
| Wells Fargo | Shahriar Pourreza | $92 | $79.42 | +31.0% | Jan 20, 2026 |
| UBS | William Appicelli | $98 | $79.93 | +39.6% | Dec 17, 2025 |
| Morgan Stanley | David Arcaro | $89 | $80.4 | +26.8% | Dec 16, 2025 |
| Morgan Stanley | Analyst unavailable | $107 | $81.51 | +52.4% | Nov 20, 2025 |
| Jefferies | Analyst unavailable | $90 | $79.86 | +28.2% | Nov 6, 2025 |
| New Street | Analyst unavailable | $83 | $81.36 | +18.2% | Nov 4, 2025 |
| Wells Fargo | Analyst unavailable | $88 | $83.45 | +25.3% | Oct 27, 2025 |
| Morgan Stanley | Analyst unavailable | $109 | $83.53 | +55.2% | Oct 22, 2025 |
| BTIG | Analyst unavailable | $98 | $83.12 | +39.6% | Oct 21, 2025 |
| Barclays | Analyst unavailable | $87 | $83.12 | +23.9% | Oct 21, 2025 |
| Barclays | Nicholas Campanella | $89 | $84.83 | +26.8% | Oct 21, 2025 |
| BMO Capital | Analyst unavailable | $85 | $84.75 | +21.1% | Oct 20, 2025 |
| Evercore ISI | Analyst unavailable | $83 | $81.84 | +18.2% | Oct 6, 2025 |
| Morgan Stanley | Analyst unavailable | $103 | $80.88 | +46.7% | Sep 25, 2025 |
| UBS | William Appicelli | $103 | $87.58 | +46.7% | Jul 25, 2025 |
| Morgan Stanley | David Arcaro | $100 | $82.1 | +42.4% | Jun 18, 2025 |
| BMO Capital | James Thalacker | $89 | $90.39 | +26.8% | Oct 21, 2024 |
| Jefferies | Paul Zimbardo | $85 | $83.31 | +21.1% | Sep 12, 2024 |
| Morgan Stanley | David Arcaro | $83 | $81.08 | +18.2% | Aug 23, 2024 |
| Evercore ISI | Greg Gordon | $80 | $78 | +13.9% | Jul 30, 2024 |
| Guggenheim | Shahriar Pourreza | $82 | $73.28 | +16.8% | Jun 17, 2024 |
| Morgan Stanley | David Arcaro | $78 | $74.83 | +11.1% | May 28, 2024 |
| Mizuho Securities | Paul Fremont | $80 | $73.96 | +13.9% | May 23, 2024 |
| BMO Capital | James Thalacker | $69 | $69.15 | -1.7% | May 1, 2024 |
| J.P. Morgan | Jeremy Tonet | $70 | $62.6 | -0.3% | Dec 4, 2023 |
Track every rating change on PEG the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationPublic Service Enterprise Group Incorporated (PSEG) is an energy provider primarily operating through its subsidiaries in the Northeastern and Mid-Atlantic United States. The company's business activities are structured into two primary segments: PSE&G and PSEG Power. The PSE&G division is responsible for transmitting electricity and distributing both electricity and natural gas to residential, commercial, and industrial customers. This segment also commits resources to solar power generation projects and various energy efficiency initiatives, as well as offering appliance service and repair.…
Historical context
All PEG earningsLatest beats and misses
Who reports nextBeat on EPS
Get the PEG recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2025-04-16T00:02:45.914612+00:00
- Polygon adjusted daily market bars · 2026-10-16T07:40:46.986828+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-16T07:40:46.984121+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-16. For educational purposes only; not investment advice.